Mirum PharmaceuticalsMIRM
那斯達克 · USD
65.72
+1.05
(+1.62%)
收盤 12/12 04:59 (UTC+8)
12/12 04:59 (UTC+8)
Mirum PharmaceuticalsMIRM
65.72
+1.05
(+1.62%)
財務數據
損益表
- 0.37
- 0.48
- 0.70
- 0.69
- 0.78
- 0.90
- 0.99
- 1.12
- 1.28
- 1.33
- 18.67
- 27.28
- 45.74
- -0.48
- 12.50
- 16.05
- 10.00
- 12.24
- 14.52
- 4.09
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | |
營業收入淨額 | 133,010 | 127,785 | 111,585 | 99,414 | 90,377 | 77,875 | 69,222 | 69,554 | 47,725 | 37,497 |
營業成本 | 25,537 | 23,421 | 23,018 | 22,780 | 20,806 | 20,227 | 17,830 | 25,020 | 10,228 | 6,812 |
營業毛利 | 107,473 | 104,364 | 88,567 | 76,634 | 69,571 | 57,648 | 51,392 | 44,534 | 37,497 | 30,685 |
營業費用 | 104,870 | 109,353 | 103,750 | 100,856 | 82,255 | 81,880 | 77,860 | 77,119 | 62,645 | 54,958 |
研發費用 | 42,960 | 46,067 | 46,044 | 44,026 | 31,710 | 32,672 | 32,222 | 30,935 | 26,117 | 22,009 |
推銷及管理費用 | 61,910 | 63,286 | 57,706 | 56,830 | 50,545 | 49,208 | 45,638 | 46,184 | 36,528 | 32,949 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | 2,603 | -4,989 | -15,183 | -24,222 | -12,684 | -24,232 | -26,468 | -32,585 | -25,148 | -24,273 |
其他收入及費用 | 3,646 | 3,119 | 5,131 | 3,435 | 2,382 | 3,798 | 5,390 | 714 | 5,383 | -45,723 |
利息費用 | 3,606 | 3,589 | 3,596 | 3,579 | 3,586 | 3,569 | 3,577 | 3,563 | 3,574 | 3,726 |
稅前純益 | 2,643 | -5,459 | -13,648 | -24,366 | -13,888 | -24,003 | -24,655 | -35,434 | -23,339 | -73,722 |
所得稅 | -262 | 402 | 1,029 | -576 | 347 | 635 | 624 | 225 | 249 | 316 |
稅後純益 | 2,905 | -5,861 | -14,677 | -23,790 | -14,235 | -24,638 | -25,279 | -35,659 | -23,588 | -74,038 |
基本每股稅後盈餘(元) | 0.06 | -0.12 | -0.30 | -0.49 | -0.30 | -0.52 | -0.54 | -0.71 | -0.57 | -1.94 |
稀釋每股稅後盈餘(元) | 0.05 | -0.12 | -0.30 | -0.49 | -0.30 | -0.52 | -0.54 | -0.72 | -0.53 | -1.95 |
基本平均股數(千股) | 50639.00 | 49726.00 | 48889.00 | 48338.00 | 47782.00 | 47235.00 | 46927.00 | 46723.00 | 41098.00 | 38107.00 |
稀釋平均股數(千股) | 56993.00 | 49726.00 | 48889.00 | 48338.00 | 47782.00 | 47235.00 | 46927.00 | 46723.00 | 41098.00 | 38107.00 |
還原基本每股稅後盈餘(元) | 0.06 | -0.12 | -0.30 | -0.49 | -0.30 | -0.52 | -0.54 | -0.71 | -0.57 | -1.94 |
還原稀釋每股稅後盈餘(元) | 0.05 | -0.12 | -0.30 | -0.49 | -0.30 | -0.52 | -0.54 | -0.72 | -0.53 | -1.95 |
還原基本平均股數(千股) | 50,639 | 49,726 | 48,889 | 48,338 | 47,782 | 47,235 | 46,927 | 46,723 | 41,098 | 38,107 |
還原稀釋平均股數(千股) | 56,993 | 49,726 | 48,889 | 48,338 | 47,782 | 47,235 | 46,927 | 46,723 | 41,098 | 38,107 |
EBITDA(千元) | 12,754 | 4,613 | -3,567 | -14,315 | -3,823 | -14,173 | -15,000 | -27,703 | -18,388 | -69,815 |